RFK (RostFarm Cooperation)

The main activity of the company as of March 2019 is wholesale trade pharmaceutical products, products used medical for purposes, perfume and cosmetic products, including soap, and cleaning products.

History

2021: Rostec bought 26% of RFK

On June 24, 2021, Rostec announced the purchase of 26% of RFK. The financial component of the transaction is not disclosed by companies.

The Rostec report says that the RFK is the only producer of alcohol-containing pharmaceutical stations in Russia, as well as antiseptics. The company also produces ethyl alcohol and a medical antiseptic solution with different concentrations of ethyl alcohol.

Rostec acquired 26% of RFK

Pharmaceutical substances manufactured by RFK are used not only for the manufacture of their own ready-made dosage forms, but also for the production of vital drugs, including vaccines. The company's product is actively purchased by leading domestic and foreign pharmaceutical enterprises.

The new shareholder represented by Rostec State Corporation is a strategically important stage in the development of RFK, a step towards solving those problems in the pharmaceutical industry that we have been engaged in for more than a year. By combining our competencies, capabilities and experience, we will be able to develop new products and compete with foreign suppliers in the domestic market, "said RFK Director General Vladimir Vereskunov.

Rostec said that the purchase of the share of the RFK corresponds to the development strategy of the state corporation aimed at expanding civilian production, including in the interests of health care. Using the competencies of RFK, Rostec intends to expand the opportunities in the development, production, storage and sale of pharmaceutical substances and drugs.

RFK is not the first pharmaceutical company among Rostec's assets. The state corporation also includes the Natsimbio holding, which is engaged in the production of immunobiological drugs important for national security. It unites key Russian pharmaceutical enterprises - NPO Microgen and FORT (a total of 10 production sites).^[1]

Notes